Back to
BlackRock Finance, Inc.
AVXL
3 quarters
Position history for
BlackRock Finance, Inc.'s holdings in Anavex Life Sciences Corp.
As of its last 13F, for Q2 2024, BlackRock Finance held 6,391,472 shares of AVXL (Anavex Life Sciences), worth $27M. It reduced the position by 254,066 shares (-3.8%) from Q1 2024. BlackRock Finance held AVXL from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
$27M
Current Shares
6.4M
Total Value Change
-$35.1M
Total Shares Change
-279,603
Quarter-by-Quarter History
Other major holders of AVXL: State Street Corp., BlackRock, Inc.